Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP631933.RAjel6W_-guDaiJ08ir1avGECGHxw18ceKwTJK9IK_9VA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP631933.RAjel6W_-guDaiJ08ir1avGECGHxw18ceKwTJK9IK_9VA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP631933.RAjel6W_-guDaiJ08ir1avGECGHxw18ceKwTJK9IK_9VA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP631933.RAjel6W_-guDaiJ08ir1avGECGHxw18ceKwTJK9IK_9VA130_provenance.
- NP631933.RAjel6W_-guDaiJ08ir1avGECGHxw18ceKwTJK9IK_9VA130_assertion description "[We tested the hypothesis that levosimendan, an inodilator that acts through calcium sensitization, opening of ATP-dependent potassium channels and phosphodiesterase III inhibition, improves cardiac function and survival in double transgenic rats harboring human renin and angiotensinogen genes (dTGRs), a model of angiotensin II (Ang II)-induced hypertensive heart failure.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP631933.RAjel6W_-guDaiJ08ir1avGECGHxw18ceKwTJK9IK_9VA130_provenance.
- NP631933.RAjel6W_-guDaiJ08ir1avGECGHxw18ceKwTJK9IK_9VA130_assertion evidence source_evidence_literature NP631933.RAjel6W_-guDaiJ08ir1avGECGHxw18ceKwTJK9IK_9VA130_provenance.
- NP631933.RAjel6W_-guDaiJ08ir1avGECGHxw18ceKwTJK9IK_9VA130_assertion SIO_000772 20811386 NP631933.RAjel6W_-guDaiJ08ir1avGECGHxw18ceKwTJK9IK_9VA130_provenance.
- NP631933.RAjel6W_-guDaiJ08ir1avGECGHxw18ceKwTJK9IK_9VA130_assertion wasDerivedFrom befree-20140225 NP631933.RAjel6W_-guDaiJ08ir1avGECGHxw18ceKwTJK9IK_9VA130_provenance.
- NP631933.RAjel6W_-guDaiJ08ir1avGECGHxw18ceKwTJK9IK_9VA130_assertion wasGeneratedBy ECO_0000203 NP631933.RAjel6W_-guDaiJ08ir1avGECGHxw18ceKwTJK9IK_9VA130_provenance.
- befree-20140225 importedOn "2014-02-25" NP631933.RAjel6W_-guDaiJ08ir1avGECGHxw18ceKwTJK9IK_9VA130_provenance.